loading
Matinas Biopharma Holdings Inc stock is traded at $0.96, with a volume of 22,358. It is up +1.05% in the last 24 hours and down -0.43% over the past month. Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$0.95
Open:
$0.959
24h Volume:
22,358
Relative Volume:
0.09
Market Cap:
$4.88M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.2004
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
+0.00%
1M Performance:
-0.43%
6M Performance:
+57.38%
1Y Performance:
+466.71%
1-Day Range:
Value
$0.95
$0.965
1-Week Range:
Value
$0.9376
$1.0034
52-Week Range:
Value
$0.09
$4.49

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name
Name
Matinas Biopharma Holdings Inc
Name
Phone
908-443-1860
Name
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Name
Employee
15
Name
Twitter
@MatinasBio
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
MTNB's Discussions on Twitter

Compare MTNB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MTNB
Matinas Biopharma Holdings Inc
0.9599 4.83M 0 -21.13M -16.95M -4.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.13 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.48 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.68 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.58 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.76 31.91B 3.81B -644.79M -669.77M -6.24

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Date Action Analyst Rating Change
May-11-21 Downgrade Piper Sandler Overweight → Neutral
Aug-26-20 Resumed Piper Sandler Overweight
Jan-27-20 Initiated Piper Sandler Overweight
Jan-24-20 Initiated SunTrust Buy
Jan-23-20 Initiated SunTrust Buy
Jan-09-20 Initiated Aegis Capital Buy
Jun-26-19 Initiated H.C. Wainwright Buy
View All

Matinas Biopharma Holdings Inc Stock (MTNB) Latest News

pulisher
Jul 24, 2025

What analysts say about Matinas BioPharma Holdings Inc. stockExceptional market positioning - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Matinas BioPharma Holdings Inc. a good long term investmentBreakthrough profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about HASI stockFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Matinas BioPharma Holdings Inc. stock performs during market volatilitySmart Return Focused Trading - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Matinas BioPharma Holdings Inc. Stock Analysis and ForecastBreakout profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Matinas BioPharma Holdings Inc. stock priceFree Stock Market Mentorship - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Is Renovaro Inc. a good long term investmentSuperior capital gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What makes Matinas BioPharma Holdings Inc. stock price move sharplyShort Squeeze Radar - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about WRAP stockOutstanding capital returns - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Hayward Holdings Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Aspergillosis Pipeline 2025: FDA Updates, Therapy - openPR.com

Jul 10, 2025
pulisher
Jul 10, 2025

Diversification Wins: Global ETFs Shine in First Half of 2025 - The Globe and Mail

Jul 10, 2025
pulisher
Jun 23, 2025

Matinas BioPharma Approves 2025 Equity Incentive Plan - TipRanks

Jun 23, 2025
pulisher
Jun 12, 2025

MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews

Jun 12, 2025
pulisher
Jun 06, 2025

Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World

Jun 06, 2025
pulisher
May 03, 2025

Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World

May 03, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com

May 02, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 17, 2025

Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World

Apr 17, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 08, 2025

Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Cap:     |  Volume (24h):